Read More 6 minute read Healthcare Industry News Can Moolec avoid delisting? Nasdaq hearing set for December 18 Moolec faces a critical Nasdaq compliance hearing over its delayed 20-F report. Explore what this means for MLEC investors and the future of molecular farming. byPallavi MadhirajuNovember 30, 2025